Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia

Cohen, 2004, Thalassemia, 14 Borgna-Pignatti, 2004, Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine, Haematologica, 89, 1187 Fischer, 1999, Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry, Am J Hematol, 60, 289, 10.1002/(SICI)1096-8652(199904)60:4<289::AID-AJH7>3.0.CO;2-W Olivieri, 1997, Iron-chelating therapy and the treatment of thalassemia, Blood, 89, 739, 10.1182/blood.V89.3.739 Anderson, 2001, Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J, 22, 2171, 10.1053/euhj.2001.2822 Brittenham, 2003, Noninvasive measurement of iron: report of an NIDDK workshop, Blood, 101, 15, 10.1182/blood-2002-06-1723 Ghugre, 2006, Improved R2* measurements in myocardial iron overload, J Magn Reson Imaging, 23, 9, 10.1002/jmri.20467 Wood, 2004, Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease, Blood, 103, 1934, 10.1182/blood-2003-06-1919 Maris, 2007, Myocardial and liver iron status using a fast T*2 quantitative MRI (T*2qMRI) technique, Magn Reson Med, 57, 742, 10.1002/mrm.21204 Di Tucci, 2008, Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias, Haematologica, 93, 1385, 10.3324/haematol.12759 Tanner, 2007, A randomized, placebo-controlled, bouble-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance, Circulation, 115, 1876, 10.1161/CIRCULATIONAHA.106.648790 Fischer, 2003, Deferiprone versus desferrioxamine in thalassemia, and T2* validation and utility, Lancet, 361, 182, 10.1016/S0140-6736(03)12222-2 Bauman, 1967, Estimation of hepatic iron stores by in vivo measurement of magnetic susceptibility, J Lab Clin Med, 70, 246 Brittenham, 1982, Magnetic-susceptibility measurement of human iron stores, N Engl J Med, 307, 1671, 10.1056/NEJM198212303072703 Fischer, 2005, Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry, Ann NY Acad Sci, 1054, 350, 10.1196/annals.1345.043 Wang, 2005, 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model, Radiology, 234, 749, 10.1148/radiol.2343031084 Bluemke, 2005, Science to practice: can MR imaging provide a noninvasive “biopsy” of the heart to measure iron levels?, Radiology, 234, 647, 10.1148/radiol.2343041670 Ogg, 1999, The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration, Magn Reson Imaging, 17, 1141, 10.1016/S0730-725X(99)00017-X Haacke, 2005, Imaging iron stores in the brain using magnetic resonance imaging, Magn Reson Imaging, 23, 1, 10.1016/j.mri.2004.10.001 Chu, 2004, MRI measurement of hepatic magnetic susceptibility-phantom validation and normal subject studies, Magn Reson Med, 52, 1318, 10.1002/mrm.20305 de Rochefort, 2008, Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field, Magn Reson Med, 60, 1003, 10.1002/mrm.21710 Wang, 1999, Magnetic resonance imaging measurement of volume magnetic susceptibility using a boundary condition, J Magn Reson, 140, 477, 10.1006/jmre.1999.1873 Dixon, 1994, Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy, Hepatology, 19, 904, 10.1002/hep.1840190416 Bush, 1995, Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues, Clin Chem, 41, 284, 10.1093/clinchem/41.2.284 Weisskoff, 1992, MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood, Magnetic Resonance in Medicine, 24, 375, 10.1002/mrm.1910240219 Ghugre, 2006, MRI detects myocardial iron in the human heart, Magn Reson Med, 56, 681, 10.1002/mrm.20981 Pennell, 2005, Calibration of myocardial T2* values in post-mortem hearts, Blood, 106, 10.1182/blood.V106.11.3837.3837 Buja, 1971, Iron in the heart. Etiology and clinical significance, Am J Med, 51, 209, 10.1016/0002-9343(71)90240-3 Sanyal, 1975, Fatal “iron heart” in an adolescent: biochemical and ultrastructural aspects of the heart, Pediatrics, 55, 336, 10.1542/peds.55.3.336 Olson, 1987, Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy, J Am Coll Cardiol, 10, 1239, 10.1016/S0735-1097(87)80124-9 Pennell, 2006, Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis, Blood, 107, 3738, 10.1182/blood-2005-07-2948